We are live on ! Find out more
6CM

683 Capital Management Portfolio holdings

AUM $1.92B
1-Year Est. Return 85.52%
This Fund
S&P 500
This Quarter Est. Return
+9.8%
1 Year Est. Return
+85.52%
3 Year Est. Return
+282.16%
5 Year Est. Return
+254.87%
10 Year Est. Return
+3,288.81%
AUM
$1.34B
AUM Growth
+$161M
Cap. Flow
+$69M
Cap. Flow %
5.14%
Top 10 Hldgs %
30.2%
Holding
355
New
45
Increased
26
Reduced
83
Closed
57

Sector Composition

Rank Sector Weight
1 Financials 26.53%
2 Healthcare 16.95%
3 Consumer Discretionary 10.09%
4 Energy 6.1%
5 Materials 5.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RNGR icon
176
Ranger Energy Services
RNGR
$375M
$169K 0.01%
16,563
ETNB
177
DELISTED
89bio
ETNB
$168K 0.01%
11,000
-11,178
-50% -$146K
KWY
178
Kingsway Corp
KWY
$260M
$167K 0.01%
+19,000
New +$167K
CMCL icon
179
Caledonia Mining Corp
CMCL
$392M
$167K 0.01%
+11,000
New +$154K
GCTS.WS
180
GCT Semiconductor Holding Warrants
GCTS.WS
$19.9M
$165K 0.01%
1,503,100
+65,600
+5% +$4.49K
PANL icon
181
Pangaea Logistics
PANL
$487M
$164K 0.01%
28,000
-8,332
-23% -$50K
LCNB icon
182
LCNB Corp
LCNB
$285M
$164K 0.01%
10,050
CLPT icon
183
ClearPoint Neuro
CLPT
$408M
$163K 0.01%
19,362
PRLD icon
184
Prelude Therapeutics
PRLD
$373M
$163K 0.01%
28,631
SI
185
PUT
DELISTED
Silvergate Capital Corporation
SI
$162K 0.01%
+100,000
New +$1.09M
INFU icon
186
InfuSystem Holdings
INFU
$236M
$160K 0.01%
20,699
-911
-4% -$8.39K
EPM icon
187
Evolution Petroleum
EPM
$127M
$159K 0.01%
25,146
ACTG icon
188
Acacia Research
ACTG
$451M
$158K 0.01%
+41,000
New +$173K
NECB icon
189
Northeast Community Bancorp
NECB
$371M
$157K 0.01%
12,000
-776
-6% -$11.6K
RAIN
190
DELISTED
Rain Oncology Inc. Common Stock
RAIN
$157K 0.01%
18,000
-6,512
-27% -$60.2K
BYRN icon
191
Byrna Technologies
BYRN
$98.9M
$156K 0.01%
20,567
SVRA icon
192
Savara
SVRA
$1.19B
$154K 0.01%
+79,000
New +$178K
WNEB icon
193
Western New England Bancorp
WNEB
$282M
$153K 0.01%
18,667
ATNM icon
194
Actinium Pharmaceuticals
ATNM
$24.7M
$151K 0.01%
16,000
-629
-4% -$6.64K
TRDA icon
195
Entrada Therapeutics
TRDA
$267M
$150K 0.01%
10,355
AGIL
196
DELISTED
AgileThought Inc
AGIL
$149K 0.01%
47,156
-117
-0.2% -$478
GLSI icon
197
Greenwich LifeSciences
GLSI
$209M
$148K 0.01%
10,747
-953
-8% -$15.1K
GHL
198
DELISTED
Greenhill & Co., Inc.
GHL
$148K 0.01%
16,667
-1,356
-8% -$15.4K
VIGL
199
DELISTED
Vigil Neuroscience
VIGL
$148K 0.01%
15,092
BKSY icon
200
BlackSky Technology
BKSY
$1.14B
$147K 0.01%
12,225

Similar funds

683 Capital Management's Q1 2023 Portfolio in Review

As of Q1 2023, 683 Capital Management held 355 positions worth $1.34B, up 14% from $1.18B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

683 Capital Management deployed $69M of net new capital in Q1 2023, opening 45 new positions and adding to 26 existing holdings. Its largest new stake was BorgWarner: 624,800 shares worth $27M.

By sector, the portfolio is most concentrated in Financials at 27% of assets, down from 33% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was Enova International, an estimated $30.4M trimmed.

  • 683 Capital Management's largest Q1 2023 buy was BorgWarner: 624,800 shares worth $27M.
  • 683 Capital Management added most to Alphabet (Google) Class A in Q1 2023, an estimated $15.6M increase.
  • 683 Capital Management's biggest Q1 2023 reduction was Enova International, cutting an estimated $30.4M.
  • 683 Capital Management fully exited Rocket Internet Growth Opportunities Corp. in Q1 2023, selling an estimated $15M.
  • 683 Capital Management's ten largest holdings make up 30% of its $1.34B portfolio in Q1 2023.
  • 683 Capital Management opened 45 new positions and closed 57 in Q1 2023.
  • 683 Capital Management's portfolio value rose 14% quarter-over-quarter to $1.34B.

Based on 683 Capital Management's 13F filing for Q1 2023, filed 15 May 2023.